The emergence of a pair of "wonder drugs" that cure Hepatitis C are driving up drug spending costs for employer sponsored health plans. But because of the effectiveness of the drugs, they are reducing overall spending in the long run.

This quid-pro-quo situation was identified by Truven Health Analytics when it reviewed private sector claims data. Truven, in producing its Healthcare Spending Index, reviewed a decade's worth of data to determine trends in health care spending. The big pop from the study came from the Hep C drug information.

"While prescription drug costs are a relatively small part of private insurance spending and showed relatively slower growth in recent years, the latest data show that prescription drug spending is now growing faster than hospital and professional spending," Truven reported. "For the four quarters ending in second quarter 2014 prescription drug spending grew 9.6 percent for the year, compared to 1.5 percent growth for the prior year. This is a direct result of the introduction of two drugs — Sovaldi and Olysio — that offer effective treatment of Hepatitis C. Together, these two drugs comprised 3.3 percent of total prescription drug spending between the fourth quarter of 2013 and the second quarter of 2014."

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.